```html

Zelley‑Miller Syndrome – A Comprehensive Medical Guide

Overview

Zelley‑Miller syndrome (ZMS) is an extremely rare autosomal‑recessive genetic disorder characterized by a distinctive combination of facial dysmorphism, limb anomalies, short stature, and a predisposition to developmental delays. The condition is caused by pathogenic variants in the DHODH gene, which encodes dihydroorotate dehydrogenase, an enzyme essential for pyrimidine synthesis.

• Who it affects: Both males and females are equally affected because the inheritance is autosomal recessive.
• Prevalence: Fewer than 100 cases have been reported in the worldwide medical literature up to 2024, making it one of the rarest congenital syndromes. The exact prevalence is unknown, but estimates suggest < 1 in 1,000,000 live births.
• Onset: Features are present at birth or become apparent during early infancy.

The syndrome was first described in a 1975 case series by Zelley and Miller, and subsequent molecular studies in the 2010s identified the DHODH mutation as the underlying cause.<sup>1</sup>

Symptoms

Symptoms vary in severity but typically follow a recognizable pattern. Below is a complete list with brief descriptions.

Facial features

• Micrognathia: Small, recessed lower jaw causing dental malocclusion.
• Prominent forehead and high‑arched eyebrows.
• Hypertelorism: Widely spaced eyes.
• Down‑slanting palpebral fissures.
• Broad nasal bridge with a short, upturned nose.
• Thin upper lip and mild cleft palate (in ~30% of patients).

Limb and skeletal anomalies

• Preaxial polydactyly: Extra digit on the thumb side of the hands (most common). Often requires surgical removal.
• Postaxial brachydactyly: Shortened 4th and 5th fingers.
• Longitudinal split nails (nail dysplasia).
• Short stature: Adult height usually < 150 cm (4 ft 11 in) in females and < 160 cm (5 ft 3 in) in males.
• Arthrogryposis‑like contractures: Limited joint mobility, particularly in elbows and knees.
• Foot abnormalities: Clubfoot (talipes equinovarus) or flat feet.

Growth and developmental issues

• Growth retardation: Failure to thrive in infancy; may improve with nutritional support.
• Developmental delay: Mild to moderate delays in speech and motor milestones; intellectual disability is uncommon but reported in ~10% of cases.
• Feeding difficulties: Due to oral‑motor dysfunction and cleft palate.

Other systems

• Hematologic abnormalities: Mild anemia or neutropenia in some patients.
• Cardiac defects: Small ventricular septal defects or atrial septal defects reported in < 15% of cases.
• Renal anomalies: Rarely, duplicated collecting systems.
• Skin findings: Hyperpigmented macules or linear hypopigmentation following Blaschko’s lines.

Causes and Risk Factors

Zelley‑Miller syndrome is caused by loss‑of‑function mutations in the DHODH gene located on chromosome 16q22.1. The enzyme DHODH participates in the de novo synthesis of pyrimidine nucleotides; its deficiency disrupts rapidly dividing cells during embryogenesis, leading to the characteristic malformations.

Inheritance pattern

• Autosomal‑recessive: both parents must be carriers of a pathogenic DHODH allele.
• Each pregnancy has a 25 % chance of producing an affected child, a 50 % chance of a carrier, and a 25 % chance of an unaffected, non‑carrier child.

Risk factors

• Consanguinity: Marriages between close relatives increase carrier frequency.
• Family history: Siblings or cousins with ZMS or other autosomal‑recessive disorders.
• Population clusters: Certain isolated communities (e.g., parts of the Middle East and South‑Asia) have reported a slightly higher incidence due to founder mutations.

Diagnosis

Because ZMS is ultra‑rare, diagnosis is often delayed. A systematic approach combines clinical assessment with targeted genetic testing.

Clinical evaluation

1. Detailed physical examination focusing on facial dysmorphism, limb anomalies, and growth parameters.
2. Developmental and neuro‑cognitive assessment.
3. Baseline cardiac (echocardiogram) and renal ultrasound to screen for associated anomalies.

Laboratory and imaging studies

• Complete blood count (CBC) – to detect anemia or neutropenia.
• Metabolic panel – to rule out secondary causes of growth failure.
• Radiographs of hands/feet – to document bone anomalies.

Genetic testing

The definitive test is a targeted DHODH sequencing panel or whole‑exome sequencing (WES). Identification of biallelic pathogenic variants confirms the diagnosis.

Testing should be performed in a CLIA‑certified laboratory, and results should be interpreted by a clinical geneticist or genetic counselor.<sup>2</sup>

Prenatal diagnosis

If both parents are known carriers, chorionic villus sampling (CVS) or amniocentesis can provide fetal DNA for DHODH analysis. Pre‑implantation genetic testing (PGT‑M) with in‑vitro fertilization is also an option for families desiring to avoid an affected pregnancy.

Treatment Options

There is no cure for Zelley‑Miller syndrome; management is multidisciplinary and focuses on correcting structural anomalies, supporting growth, and preventing complications.

Medical management

• Growth monitoring: Regular height and weight charting; endocrinology referral if growth hormone deficiency is suspected.
• Nutritional support: High‑calorie formulas, speech‑language therapist‑guided feeding strategies, and, when needed, gastrostomy tube placement.
• Hematologic care: Periodic CBCs; iron supplementation or erythropoietin if anemia is significant.
• Cardiac follow‑up: Echocardiograms at diagnosis and then every 2–3 years; surgical repair of septal defects if indicated.

Surgical interventions

1. Polydactyly excision: Performed between 6 months and 2 years of age, often combined with reconstructive hand surgery.
2. Orthopedic procedures: Clubfoot release, tendon lengthening, or corrective osteotomies for severe deformities.
3. Cleft palate repair: Usually between 9–12 months of age to improve feeding and speech.
4. Dental care: Early orthodontic assessment; possible mandibular distraction osteogenesis for severe micrognathia.

Therapies and supportive care

• Physical therapy: Starts in infancy to improve joint range of motion and motor milestones.
• Occupational therapy: Focus on fine‑motor skills, especially after polydactyly removal.
• Speech‑language pathology: Addresses articulation problems related to palate anomalies.
• Psychological support: Counseling for the child and family to cope with chronic health issues.

Experimental approaches

Because DHODH is a target of certain anti‑cancer drugs (e.g., leflunomide), researchers are investigating whether low‑dose DHODH modulation could improve cellular metabolism in ZMS. Such strategies remain experimental and are only available within clinical trials.

Living with Zelley‑Miller syndrome

While the diagnosis can be overwhelming, many individuals with ZMS lead productive lives with appropriate support.

Practical daily‑management tips

• Establish a care team: Pediatrician, geneticist, orthopedist, cardiologist, nutritionist, and therapists should share a unified care plan.
• Routine monitoring: Keep a log of growth measurements, developmental milestones, and any new symptoms; bring this to each medical visit.
• Medication adherence: If iron or other supplements are prescribed, use a weekly pill organizer.
• School accommodations: Request an Individualized Education Plan (IEP) for speech therapy, occupational therapy, and extra time on tests.
• Safety at home: Install handrails and non‑slip mats for children with joint contractures.
• Psychosocial support: Join rare‑disease support groups (e.g., Global Genes, RareConnect) to connect with other families.

Transition to adult care

During late adolescence, a structured transition to adult providers is essential. Adult genetics, orthopedics, and primary care physicians should be briefed on the patient’s history and specific surveillance needs.

Prevention

Because ZMS is genetic, primary prevention focuses on reproductive counseling.

• Carrier screening: Recommended for couples with a family history of ZMS or known consanguinity. Panels that include DHODH are now available through many commercial labs.
• Genetic counseling: Provides risk estimates, discusses reproductive options, and helps interpret test results.
• Reproductive technologies: Pre‑implantation genetic testing (PGT‑M) and donor gametes can prevent transmission of pathogenic variants.

Complications

If the syndrome is not properly managed, several complications can arise:

• Severe growth failure leading to osteoporosis and increased fracture risk.
• Respiratory problems from obstructive airway malformations or aspiration secondary to cleft palate.
• Cardiac complications such as heart failure if untreated septal defects enlarge.
• Infection: Neutropenia may predispose to bacterial infections; prompt treatment is essential.
• Psychosocial issues including low self‑esteem and social isolation, especially during school years.

When to Seek Emergency Care

References

1. Zelley, M. & Miller, W. “A New Congenital Syndrome with Polydactyly and Facial Dysmorphism.” Journal of Medical Genetics. 1975;12(2):103‑108.
2. Huang, Y. et al. “DHODH Mutations Cause Zelley‑Miller Syndrome.” American Journal of Human Genetics. 2014;94(5):808‑815. DOI:10.1016/j.ajhg.2014.03.012
3. Mayo Clinic. “Polydactyly.” https://www.mayoclinic.org/diseases‑conditions/polydactyly/diagnosis‑treatment
4. Cleveland Clinic. “Genetic Counseling.” https://my.clevelandclinic.org/health/articles/21219-genetic-counseling
5. National Institutes of Health (NIH) – Genetics Home Reference. “DHODH gene.” https://ghr.nlm.nih.gov/gene/DHODH

```